EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers

Fangcen Liu, Fangfang Zhong, Huan Wu, Keying Che, Jiaochun Shi, Nandie Wu, Yao Fu, Yue Wang, Jing Hu, Xiaoping Qian, Xiangshan Fan, Weifeng Wang und 1 weitere

The Oncologist · 2023

DOI: 10.1093/oncolo/oyac268 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Oncologist, 2023. Verfasst von Fangcen Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Nanjing, People's Republic of China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Endometrial Neoplasms, Stomach Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science and Technology of the People's Republic of China, Department of Science and Technology of Jilin Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microsatellite instability (MSI) has emerged as an important predictor of sensitivity for immunotherapy-based strategies. β-2-Microglobulin (B2M) contains microsatellites within the coding regions and is prone to somatic changes in MSI/mismatch repair deficiency (MSI/dMMR) tumors. To delineate prevalence and associations of B2M mutations in MSI-H/dMMR cancers, we investigated the mutational profile of B2M and clinical and pathological features in gastric cancer (GC), colorectal cancer (CRC), and endometrial cancer (EC) with a high incidence of microsatellite instability-high (MSI-H)/dMMR. Formalin-fixed paraffin-embedded (FFPE) tumor tissues along with matched normal tissues were collected from 108 MSI/dMMR patients with GC, CRC, and EC. Genomic profiling of tissue and blood samples were assessed next-generation sequencing (NGS). Immunohistochemistry (IHC) was used to examine the presence or absence of B2M protein. Alternations in the exonic microsatellite regions of B2M were observed at various but high frequencies (57.5% in CRC, 23.9% in GC, and 13.6% in EC) and in different forms. NGS assay revealed that genes involved in chromatin regulation, the PI3K pathway, the WNT pathway, and mismatch repair were extensively altered in the MSI-H cohort. Signature 6 and 26, 2 of 4 mutational signatures associated with defective DNA mismatch repair, featured with high numbers of small insertion/deletions (INDEL) dominated in all 3 types of cancer. Alternations in the exonic microsatellite regions of B2M were observed at various but high frequencies (57.5% in CRC, 23.9% in GC, and 13.6% in EC) and in different forms. Tumor mutational burden (TMB) was significantly higher in the patients carrying MSI-H/dMMR tumors with B2M mutation than that in patients with wild-type B2M (P = .026).The frame shift alteration occurring at the exonic microsatellite sties caused loss of function of B2M gene. In addition, a case with CRC carrying indels in B2M gene resisted the ICI treatment was reported. In conclusion, patients carrying MSI-H/dMMR tumors with B2M mutation showed significantly higher TMB. Prescription of ICIs should be thoroughly evaluated for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEndometrial NeoplasmsStomach NeoplasmsBrain NeoplasmsNeoplastic Syndromes, HereditaryFemaleMutationHumansPrevalenceDNA Mismatch RepairMicrosatellite InstabilityPhosphatidylinositol 3-Kinases

Stichwörter der Autor:innen

B2MMSI/dMMRacquired resistanceimmune checkpoint inhibitor therapyprimary resistance

Substanzen

Phosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Department of Pathology, Affiliated Drum Tower Hospital to Medical School of Nanjing University, Nanjing, People's Republic of China.
  • Department of Pathology, Margaret Williamson Red House Hospital, Shanghai, People's Republic of China.
  • Department of R&D, OrigiMed, Shanghai, People's Republic of China.
  • The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School & Clinical Cancer Institute of Nanjing University, Nanjing, People's Republic of China.

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Department of Science and Technology of Jilin Province

Zitieren

APA

Liu, F., Zhong, F., Wu, H., Che, K., Shi, J., Wu, N., Fu, Y., Wang, Y., Hu, J., Qian, X., Fan, X., Wang, W., & Wei, J. (2023). Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers. The Oncologist. https://doi.org/10.1093/oncolo/oyac268

Vancouver

Liu F, Zhong F, Wu H, Che K, Shi J, Wu N, et al. Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers. The Oncologist. 2023. doi:10.1093/oncolo/oyac268

BibTeX
@article{Liu2023,
  author = {Liu, Fangcen and Zhong, Fangfang and Wu, Huan and Che, Keying and Shi, Jiaochun and Wu, Nandie and Fu, Yao and Wang, Yue and Hu, Jing and Qian, Xiaoping and Fan, Xiangshan and Wang, Weifeng and Wei, Jia},
  title = {Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers},
  journal = {The Oncologist},
  year = {2023},
  doi = {10.1093/oncolo/oyac268}
}
Kostenlos starten →